Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Debating when to call cancer by its name

Sarah Brown
CMAJ April 29, 2019 191 (17) E483-E484; DOI: https://doi.org/10.1503/cmaj.109-5737
Sarah Brown
Ottawa, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Cancer. A diagnosis that terrifies patients and their families; a term that can be unnerving even for physicians. When cancer becomes part of the conversation, patients feel threatened, anxiety levels skyrocket, and imaginations jump to worst-case scenarios.

That assumption formed the basis for a recent debate in BMJ. A surgeon and breast cancer oncology specialist argued that relabelling ultralow risk tumours to avoid the word cancer would spare patients psychological trauma and make it easier for physicians to de-escalate treatment when appropriate. A histopathologist countered that using alternate names could cause confusion and the answer was better education.

“The debate over the word ‘cancer’ really boils down to a debate about the art of medicine — how we communicate, both verbally and nonverbally, when we speak with patients,” says Dr. Isaac Bogoch, a general internist and infectious disease physician at Toronto General Hospital. “I believe we should always be using the correct term, even if the correct term includes the word ‘cancer.’”

Discussion among his colleagues has focussed not on whether to use the word “cancer,” but on how best to relay important information in a way that’s transparent, respectful and understandable to create an environment of trust and clarity.

The word “cancer” holds a lot of power. But so, too, do the thousands of other words doctors use in conversations with patients. “We need to be better as communicators,” said Bogoch. “We need to always be setting the stage, so our patients are informed about the possibilities and next steps.”

Figure

Physicians must balance sensitivity with clarity when delivering a diagnosis.

Image courtesy of Tashi-Delek/iStock

Indeed, using the word “cancer” can be empowering, according to Rosana Faria, a clinical psychologist at St. Mary’s Hospital Center in Montreal. “There is this idea that saying ‘cancer’ might generate anxiety and depression, but that’s not necessarily the case,” said Faria. “In the long run, information is power, and patients feel better if they know they are receiving full and accurate information.”

Though he comes at the debate from a different angle, clinical ethicist Brendan Leier reaches the same conclusion. In Canada, the standard for consent is a rigorous one, with a number of legal cases making it clear that the burden of responsibility for a patient’s understanding falls on the physician. Using euphemisms or overly technical language both risk muddying the waters.

If patients are going to provide informed consent — to map what their doctors are telling them into their lives in a meaningful way — they have to be very clear on what their doctors are saying, said Leier, who works out of the John Dossetor Health Ethics Centre in Alberta. “If respect for autonomy is the value, consent is the tool. It is the instrument that allows us to get to the heart of the matter. So when we’re talking about individuals, that’s very important.”

Leier said he encountered the best example of this important lesson not as a clinical ethicist but when he was working his way through school as a bartender. One night, a regular customer got into a fight at the bar and ended up getting punched in the mouth. Weeks later, the man stopped by the bar again. He told Leier that he had been a brass player, studying music at the university, but had to drop out because he’d lost feeling in one half of his lip since the fight and subsequent treatment in an emergency room.

“Obviously, you can’t ask everyone coming into ER if they play a brass instrument, but it really illustrates how important the process of consent is,” said Leier. If the resident in the ER who treated the man had mentioned there was risk of nerve damage, the musician may have opted for a surgical specialist. For most people, losing a bit of feeling in a lip would be no big deal, but for this man it had major consequences. “It all comes down to: You can never appropriately assume anything — you don’t know people’s lives or how they’ll assess risk.”

Footnotes

  • Posted on cmajnews.com on Apr. 10, 2019.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 191 (17)
CMAJ
Vol. 191, Issue 17
29 Apr 2019
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Debating when to call cancer by its name
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Debating when to call cancer by its name
Sarah Brown
CMAJ Apr 2019, 191 (17) E483-E484; DOI: 10.1503/cmaj.109-5737

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Debating when to call cancer by its name
Sarah Brown
CMAJ Apr 2019, 191 (17) E483-E484; DOI: 10.1503/cmaj.109-5737
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Is one-way masking enough?
  • XE, XD & XF: what to know about the Omicron hybrid variants
  • 5 infectious disease topics to watch
Show more News

Similar Articles

Collections

  • Topics
    • Cancer & oncology
    • Medical ethics

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire